James S. Hagood

9.8k total citations · 1 hit paper
101 papers, 5.7k citations indexed

About

James S. Hagood is a scholar working on Pulmonary and Respiratory Medicine, Molecular Biology and Surgery. According to data from OpenAlex, James S. Hagood has authored 101 papers receiving a total of 5.7k indexed citations (citations by other indexed papers that have themselves been cited), including 67 papers in Pulmonary and Respiratory Medicine, 37 papers in Molecular Biology and 16 papers in Surgery. Recurrent topics in James S. Hagood's work include Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (37 papers), Neonatal Respiratory Health Research (31 papers) and Cell Adhesion Molecules Research (13 papers). James S. Hagood is often cited by papers focused on Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (37 papers), Neonatal Respiratory Health Research (31 papers) and Cell Adhesion Molecules Research (13 papers). James S. Hagood collaborates with scholars based in United States, Mexico and Canada. James S. Hagood's co-authors include Tanya A. Rege, Yan Y. Sanders, Namasivayam Ambalavanan, William D. Hardie, Stephan W. Glasser, Thomas H. Barker, Joanne E. Murphy-Ullrich, Vanessa J. Craig, Li Zhang and Caroline A. Owen and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Journal of Clinical Investigation.

In The Last Decade

James S. Hagood

98 papers receiving 5.6k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Matrix Metalloproteinases as Therapeutic Targets for Idiopathic Pulmonary Fibrosis

2015 348 citations Vanessa J. Craig, Li Zhang et al. American Journal of Respiratory Cell and Molecular Biology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
James S. Hagood United States	43	2.8k	1.9k	918	726	563	101	5.7k
Jeffrey C. Horowitz United States	38	2.6k 0.9×	1.9k 1.0×	790 0.9×	571 0.8×	630 1.1×	82	5.8k
Carla F. Kim United States	33	2.1k 0.7×	2.6k 1.4×	977 1.1×	1.3k 1.8×	422 0.7×	63	5.3k
Joseph A. Lasky United States	39	2.7k 1.0×	1.4k 0.7×	449 0.5×	607 0.8×	422 0.7×	109	4.7k
Frank Strutz Germany	42	1.5k 0.5×	3.2k 1.7×	1.2k 1.3×	1.1k 1.5×	1.1k 2.0×	97	7.8k
Yan Xu United States	53	3.5k 1.2×	3.9k 2.0×	1.6k 1.7×	569 0.8×	993 1.8×	146	7.8k
Gail Deutsch United States	36	2.1k 0.8×	1.7k 0.9×	1.8k 2.0×	511 0.7×	468 0.8×	111	5.3k
Katsuo Sueishi Japan	47	1.5k 0.5×	2.7k 1.4×	1.6k 1.7×	907 1.2×	809 1.4×	203	7.5k
Christina E. Barkauskas United States	17	3.1k 1.1×	1.4k 0.7×	1.4k 1.5×	392 0.5×	302 0.5×	27	4.5k
Maria G. Frid United States	44	3.6k 1.3×	3.0k 1.6×	1.1k 1.2×	529 0.7×	761 1.4×	79	7.6k
Kjetil Ask Canada	36	2.5k 0.9×	1.3k 0.7×	488 0.5×	355 0.5×	605 1.1×	94	4.7k

Countries citing papers authored by James S. Hagood

Since Specialization

Citations

This map shows the geographic impact of James S. Hagood's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by James S. Hagood with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites James S. Hagood more than expected).

Fields of papers citing papers by James S. Hagood

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by James S. Hagood. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by James S. Hagood. The network helps show where James S. Hagood may publish in the future.

Co-authorship network of co-authors of James S. Hagood

This figure shows the co-authorship network connecting the top 25 collaborators of James S. Hagood. A scholar is included among the top collaborators of James S. Hagood based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with James S. Hagood. James S. Hagood is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Li, Rongbo, Naoyuki Sone, Shimpei Gotoh, Xin Sun, & James S. Hagood. (2023). Contemporary and emerging technologies for research in children's rare and interstitial lung disease. Pediatric Pulmonology. 59(9). 2349–2359. 1 indexed citations

Hu, Ping, Lisette Leyton, James S. Hagood, & Thomas H. Barker. (2022). Thy-1-Integrin Interactions in cis and Trans Mediate Distinctive Signaling. Frontiers in Cell and Developmental Biology. 10. 928510–928510. 11 indexed citations

Duong, Thu Elizabeth, Yan Wu, Brandon C. Sos, et al.. (2022). A single-cell regulatory map of postnatal lung alveologenesis in humans and mice. Cell Genomics. 2(3). 100108–100108. 17 indexed citations

Martin, Marcy, Jiao Zhang, Yifei Miao, et al.. (2021). Role of endothelial cells in pulmonary fibrosis via SREBP2 activation. JCI Insight. 6(22). 39 indexed citations

Nishio, Takahiro, Yukinori Koyama, Xiao Liu, et al.. (2021). Immunotherapy-based targeting of MSLN ⁺ activated portal fibroblasts is a strategy for treatment of cholestatic liver fibrosis. Proceedings of the National Academy of Sciences. 118(29). 15 indexed citations

Tamburro, Robert F., Kenneth R. Cooke, Stella M. Davies, et al.. (2020). Pulmonary Complications of Pediatric Hematopoietic Cell Transplantation. A National Institutes of Health Workshop Summary. Annals of the American Thoracic Society. 18(3). 381–394. 26 indexed citations

Liptzin, Deborah R., Kaci Pickett, John T. Brinton, et al.. (2020). Neuroendocrine Cell Hyperplasia of Infancy. Clinical Score and Comorbidities. Annals of the American Thoracic Society. 17(6). 724–728. 23 indexed citations

Fiore, Vincent F., Simon S. Wong, Chunting Tan, et al.. (2018). αvβ3 Integrin drives fibroblast contraction and strain stiffening of soft provisional matrix during progressive fibrosis. JCI Insight. 3(20). 91 indexed citations

Wong, Simon S., Carmen A. Taype, Tzu‐Pin Shentu, et al.. (2017). Thy-1 interaction with Fas in lipid rafts regulates fibroblast apoptosis and lung injury resolution. Laboratory Investigation. 97(3). 256–267. 44 indexed citations

10.

Craig, Vanessa J., Li Zhang, James S. Hagood, & Caroline A. Owen. (2015). Matrix Metalloproteinases as Therapeutic Targets for Idiopathic Pulmonary Fibrosis. American Journal of Respiratory Cell and Molecular Biology. 53(5). 585–600. 348 indexed citations breakdown →

11.

Hagood, James S.. (2014). Beyond the Genome: Epigenetic Mechanisms in Lung Remodeling. Physiology. 29(3). 177–185. 39 indexed citations

12.

Kurland, Geoffrey, Robin R. Deterding, James S. Hagood, et al.. (2013). An Official American Thoracic Society Clinical Practice Guideline: Classification, Evaluation, and Management of Childhood Interstitial Lung Disease in Infancy. American Journal of Respiratory and Critical Care Medicine. 188(3). 376–394. 279 indexed citations

13.

Sanders, Yan Y., Namasivayam Ambalavanan, Brian Halloran, et al.. (2012). Altered DNA Methylation Profile in Idiopathic Pulmonary Fibrosis. American Journal of Respiratory and Critical Care Medicine. 186(6). 525–535. 185 indexed citations

14.

Varisco, Brian M., Namasivayam Ambalavanan, Jeffrey A. Whitsett, & James S. Hagood. (2012). Thy-1 Signals through PPARγ to Promote Lipofibroblast Differentiation in the Developing Lung. American Journal of Respiratory Cell and Molecular Biology. 46(6). 765–772. 53 indexed citations

15.

Sanders, Yan Y., José Cisneros, Gerard J. Nuovo, Moisés Selman, & James S. Hagood. (2012). Epigenetic Regulation Mediates Thy-1 Gene Silencing and Induction of the Myofibroblast Phenotype. 3 indexed citations

16.

Vayalil, Praveen K., et al.. (2011). Therapeutic Value of Small Molecule Inhibitor to Plasminogen Activator Inhibitor–1 for Lung Fibrosis. American Journal of Respiratory Cell and Molecular Biology. 46(1). 87–95. 74 indexed citations

17.

Glasser, Stephan W., William D. Hardie, & James S. Hagood. (2010). Pathogenesis of Interstitial Lung Disease in Children and Adults. Pediatric Allergy Immunology and Pulmonology. 23(1). 9–14. 30 indexed citations

18.

Sanders, Yan Y., Trygve O. Tollefsbol, Brian M. Varisco, & James S. Hagood. (2010). Epigenetic Regulation of Thy-1 by Histone Deacetylase Inhibitor in Rat Lung Fibroblasts. American Journal of Respiratory Cell and Molecular Biology. 45(1). 16–23. 90 indexed citations

19.

Hagood, James S., et al.. (2010). ChILD Family Education. Pediatric Allergy Immunology and Pulmonology. 23(1). 87–90. 6 indexed citations

20.

Rege, Tanya A. & James S. Hagood. (2006). Thy-1, a versatile modulator of signaling affecting cellular adhesion, proliferation, survival, and cytokine/growth factor responses. Biochimica et Biophysica Acta (BBA) - Molecular Cell Research. 1763(10). 991–999. 146 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact